Masimo Corp (MASI)
169.12
+4.17
(+2.53%)
USD |
NASDAQ |
Nov 21, 16:00
169.21
+0.09
(+0.05%)
After-Hours: 20:00
Masimo Revenue (Quarterly): 504.60M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 504.60M |
| June 30, 2024 | 496.30M |
| March 31, 2024 | 492.80M |
| December 31, 2023 | 548.90M |
| September 30, 2023 | 478.90M |
| June 30, 2023 | 455.30M |
| March 31, 2023 | 565.00M |
| December 31, 2022 | 617.00M |
| September 30, 2022 | 549.30M |
| June 30, 2022 | 565.30M |
| March 31, 2022 | 304.20M |
| December 31, 2021 | 327.60M |
| September 30, 2021 | 307.40M |
| June 30, 2021 | 305.10M |
| March 31, 2021 | 299.04M |
| December 31, 2020 | 295.01M |
| September 30, 2020 | 278.11M |
| June 30, 2020 | 300.95M |
| March 31, 2020 | 269.62M |
| December 31, 2019 | 247.51M |
| September 30, 2019 | 229.01M |
| June 30, 2019 | 229.65M |
| March 31, 2019 | 231.66M |
| December 31, 2018 | 223.13M |
| September 30, 2018 | 210.58M |
| Date | Value |
|---|---|
| June 30, 2018 | 211.62M |
| March 31, 2018 | 212.95M |
| December 31, 2017 | 207.94M |
| September 30, 2017 | 193.36M |
| June 30, 2017 | 192.31M |
| March 31, 2017 | 196.64M |
| December 31, 2016 | 201.47M |
| September 30, 2016 | 167.62M |
| June 30, 2016 | 172.64M |
| March 31, 2016 | 171.17M |
| December 31, 2015 | 167.27M |
| September 30, 2015 | 152.58M |
| June 30, 2015 | 155.73M |
| March 31, 2015 | 154.54M |
| December 31, 2014 | 161.79M |
| September 30, 2014 | 144.12M |
| June 30, 2014 | 140.92M |
| March 31, 2014 | 139.81M |
| December 31, 2013 | 142.43M |
| September 30, 2013 | 131.45M |
| June 30, 2013 | 137.42M |
| March 31, 2013 | 135.94M |
| December 31, 2012 | 132.16M |
| September 30, 2012 | 119.07M |
| June 30, 2012 | 122.78M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
247.51M
Minimum
Dec 2019
617.00M
Maximum
Dec 2022
410.40M
Average
391.45M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Baxter International Inc | 2.699B |
| Intuitive Surgical Inc | 2.038B |
| Tandem Diabetes Care Inc | 243.97M |
| Glaukos Corp | 96.67M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.80M |
| Total Expenses (Quarterly) | 474.50M |
| EPS Diluted (Quarterly) | 0.18 |
| Enterprise Value | 9.669B |
| Gross Profit Margin (Quarterly) | 52.16% |
| Profit Margin (Quarterly) | 1.94% |
| Earnings Yield | 0.86% |
| Operating Earnings Yield | 1.71% |
| Normalized Earnings Yield | 1.160 |